Skip to Main Content

Paper Details

Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers.
Nat Commun
55
2016
Aromatase, ER, ER+ breast cancer, ER+ breast cancer genome, ESR1, NAI, aromatase, breast cancer, estrogen, estrogen-receptor, estrogen-receptor-positive breast cancers, oestrogen, oestrogen-receptor, oestrogen-receptor-positive (ER+) breast cancer, primary tumours, tumour, tumour RNA, tumours
Author NameAffiliation
Christopher A MillerMcDonnell Genome Institute, Washington University School of Medicine
Christopher A MillerWashington University School of Medicine
Yevgeniy GindinMcDonnell Genome Institute, Washington University School of Medicine
Yevgeniy GindinMcDonnell Genome Institute, Washington University School of Medicine
Charles LuMcDonnell Genome Institute, Washington University School of Medicine
Obi L GriffithMcDonnell Genome Institute, Washington University School of Medicine
Obi L GriffithWashington University School of Medicine
Obi L GriffithSiteman Cancer Center, Washington University School of Medicine
Malachi GriffithMcDonnell Genome Institute, Washington University School of Medicine
Malachi GriffithSiteman Cancer Center, Washington University School of Medicine
Malachi GriffithWashington University School of Medicine
Jeremy HoogWashington University School of Medicine
David E LarsonMcDonnell Genome Institute, Washington University School of Medicine
David E LarsonWashington University School of Medicine
Mark A WatsonWashington University School of Medicine
Sherri R DaviesWashington University School of Medicine
Kelly K HuntMD Anderson Cancer Center
Kelly K HuntMD Anderson Cancer Center
Vera J SumanMayo Clinic
Jacqueline SniderWashington University School of Medicine
Tom WalshWashington University School of Medicine
Tom WalshWashington University School of Medicine
Graham A ColditzSiteman Cancer Center, Washington University School of Medicine
Graham A ColditzWashington University School of Medicine
Graham A ColditzSiteman Cancer Center, Washington University School of Medicine
Graham A ColditzWashington University School of Medicine
Richard K WilsonMcDonnell Genome Institute, Washington University School of Medicine
Richard K WilsonWashington University School of Medicine
Richard K WilsonSiteman Cancer Center, Washington University School of Medicine
Richard K WilsonWashington University School of Medicine
Richard K WilsonWashington University School of Medicine
Richard K WilsonMcDonnell Genome Institute, Washington University School of Medicine
Richard K WilsonWashington University School of Medicine
Richard K WilsonWashington University School of Medicine
Richard K WilsonSiteman Cancer Center, Washington University School of Medicine
Richard K WilsonWashington University School of Medicine
Elaine R MardisMcDonnell Genome Institute, Washington University School of Medicine
Elaine R MardisWashington University School of Medicine
Elaine R MardisSiteman Cancer Center, Washington University School of Medicine
Elaine R MardisWashington University School of Medicine
Elaine R MardisMcDonnell Genome Institute, Washington University School of Medicine
Elaine R MardisWashington University School of Medicine
Elaine R MardisSiteman Cancer Center, Washington University School of Medicine
Elaine R MardisWashington University School of Medicine
Matthew J EllisMcDonnell Genome Institute, Washington University School of Medicine
Matthew J EllisWashington University School of Medicine
Matthew J EllisBaylor College of Medicine
  • 1 - 47

Datasets